Concepedia

Publication | Open Access

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study

94

Citations

23

References

2020

Year

Abstract

Therapy with dupilumab led to a significant improvement of AD over a 16-week treatment period, with a good safety profile. Therefore, dupilumab could be considered as an efficacious and safe treatment for AD also in the elderly.

References

YearCitations

Page 1